Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum
Identification
- Clé publique
- radar:r-08e7650e9c34d89d82d0e9036eaa0190
- Auteurs
- Baixun He · Jie Fu · Chong Chen · Wenxin Zhang · Shuang Li · Cherie S. Tan · Dong Ming
- Année déclarée
- 2025
- Langue déclarée
- en
- Type source
- article
- Première détection
- 2026-11-14T02:03:29.550623+00:00
- Dernière observation des métadonnées
- 2026-11-14T02:03:29.550623+00:00
- Dernière vérification HTTP
- Non effectuée
Institutions déclarées par la source
Tianjin University · Nankai University · Tianjin Medical University Cancer Institute and Hospital
Pays d’affiliation déclarés
CN
Résumé documentaire — langue originale
The target neutrophil-activating peptide-2, NAP2, is a potential biomarker for early lung cancer diagnosis, whereas there are currently no precise techniques for differentiating NAP2 from its precursors. To overcome this difficulty, we created an electrochemical aptamer-based sensor (E-AB) consisting of the 33-mer aptamer domain, a 2-bp three-junction region, and two conductive signal reporter stems. Whereas E-AB-AT and E-AB-RAN sensors with two (AT) 6 or N 12 stems, respectively, were unable to distinguish between platelet basic protein (PBP) (94 aa) and NAP2 (70 aa). However, in contrast, the E-AB-GC sensor with two (GC) 6 stems could selectively detect NAP2 but hardly recorded PBP. Here, we developed an E-AB-GC point-of-care test (POCT) technique to detect NAP2 away from its precursors in 10 μL of human serum and provide concentration data in 5 min. Interestingly, serum NAP2 levels in human samples, as determined by the E-AB-GC sensor, were roughly 30–50% lower than those obtained by ELISA. Results also showed that E-AB-GC analysis of serum NAP2 in patients in stages I through IV revealed statistical significance and an excellent guiding function in the early diagnosis of lung cancer, particularly for patients in stage I cancer ( p = 0.0054, area under the curve, 0.95). Importantly, this E-AB-GC POCT platform has shown potential as an on-site quick diagnostic tool, which can also be used to detect other lung cancer markers. Our research on the impacts of stem sequencing on sensing capabilities might assist in the future development of E-AB biomarker sensors.
Identifiants
- OPENALEX
- https://openalex.org/W4409381364
- DOI
- 10.1021/acs.analchem.4c06815
- PMID
- https://pubmed.ncbi.nlm.nih.gov/40215095
Repères documentaires
- Famille documentaire
- article
- Types déclarés par les sources
- article
- Éditeurs
- American Chemical Society
Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.
Sources
OpenAlex · Document 1
Citer cette référence
Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. 2025. https://doi.org/10.1021/acs.analchem.4c06815
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.
- APA
- Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. (2025). Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. https://doi.org/10.1021/acs.analchem.4c06815
- Chicago
- Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. 2025. https://doi.org/10.1021/acs.analchem.4c06815
- ISO 690
- Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. 2025. https://doi.org/10.1021/acs.analchem.4c06815
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR — Bibliothèque juridique mondiale des droits de la Nature. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-08e7650e9c34d89d82d0e9036eaa0190/ · Dernière vérification HTTP : non effectuée
Données de cette version figée
Dossiers et relations documentaires
Rôles des sources
Source bibliographique / publication d’origine · https://doi.org/10.1021/acs.analchem.4c06815
Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.
Statut documentaire
Pertinence à examiner
Bibliothèque
Cette identité n’est pas encore intégrée à la Bibliothèque juridique.